Edward P. Harvey
Affiliations: | Dana-Farber Cancer Institute, Boston, MA, United States |
Google:
"Edward Harvey"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pinch BJ, Buckley DL, Gleim S, et al. (2021) A strategy to assess the cellular activity of E3 ligase components against neo-substrates using electrophilic probes. Cell Chemical Biology |
| Cathcart AM, Bird GH, Wales TE, et al. (2020) Targeting a helix-in-groove interaction between E1 and E2 blocks ubiquitin transfer. Nature Chemical Biology |
| Hauseman ZJ, Harvey EP, Newman CE, et al. (2020) Homogeneous Oligomers of Pro-apoptotic BAX Reveal Structural Determinants of Mitochondrial Membrane Permeabilization. Molecular Cell |
| Harvey EP, Hauseman ZJ, Cohen DT, et al. (2020) Identification of a Covalent Molecular Inhibitor of Anti-apoptotic BFL-1 by Disulfide Tethering. Cell Chemical Biology |
| Ben-Nun Y, Seo HS, Harvey EP, et al. (2020) Identification of a Structural Determinant for Selective Targeting of HDMX. Structure (London, England : 1993) |
| Guerra RM, Bird GH, Harvey EP, et al. (2018) Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer. Cell Reports. 24: 3393-3403.e5 |
| Harvey EP, Seo HS, Guerra RM, et al. (2018) Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor. Structure (London, England : 1993). 26: 153-160.e4 |
| Huhn AJ, Guerra RM, Harvey EP, et al. (2016) Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors. Cell Chemical Biology |